These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37292932)

  • 1. Left Ventricular Fibrosis and CMR Tissue Characterization of Papillary Muscles in Mitral Valve Prolapse Patients.
    Spampinato RA; Marin-Cuartas M; Kampen A; Fahr F; Sieg F; Strotdrees E; Jahnke C; Klaeske K; Wiesner K; Morningstar JE; Nagata Y; Izquierdo-Garcia D; Dieterlen MT; Norris RA; Levine RA; Paetsch I; Borger MA
    Res Sq; 2023 May; ():. PubMed ID: 37292932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular fibrosis and CMR tissue characterization of papillary muscles in mitral valve prolapse patients.
    Spampinato RA; Marin-Cuartas M; van Kampen A; Fahr F; Sieg F; Strotdrees E; Jahnke C; Klaeske K; Wiesner K; Morningstar JE; Nagata Y; Izquierdo-Garcia D; Dieterlen MT; Norris RA; Levine RA; Paetsch I; Borger MA
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):213-224. PubMed ID: 37891450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dark-blood late gadolinium enhancement CMR improves detection of papillary muscle fibrosis in patients with mitral valve prolapse.
    Van De Heyning CM; Holtackers RJ; Nazir MS; Grapsa J; Demetrescu C; Pype L; Chiribiri A
    Eur J Radiol; 2022 Feb; 147():110118. PubMed ID: 34972057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Gadolinium Enhancement of Left Ventricular Papillary Muscles in Patients with Mitral Regurgitation.
    Lim SJ; Koo HJ; Cho MS; Nam GB; Kang JW; Yang DH
    Korean J Radiol; 2021 Oct; 22(10):1609-1618. PubMed ID: 34402246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.
    Pradella S; Grazzini G; Brandani M; Calistri L; Nardi C; Mori F; Miele V; Colagrande S
    Eur Radiol; 2019 Mar; 29(3):1546-1554. PubMed ID: 30088066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse.
    Pavon AG; Arangalage D; Pascale P; Hugelshofer S; Rutz T; Porretta AP; Le Bloa M; Muller O; Pruvot E; Schwitter J; Monney P
    J Cardiovasc Magn Reson; 2021 Sep; 23(1):102. PubMed ID: 34517908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance characterization of mitral valve prolapse.
    Han Y; Peters DC; Salton CJ; Bzymek D; Nezafat R; Goddu B; Kissinger KV; Zimetbaum PJ; Manning WJ; Yeon SB
    JACC Cardiovasc Imaging; 2008 May; 1(3):294-303. PubMed ID: 19356441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia.
    Constant Dit Beaufils AL; Huttin O; Jobbe-Duval A; Senage T; Filippetti L; Piriou N; Cueff C; Venner C; Mandry D; Sellal JM; Le Scouarnec S; Capoulade R; Marrec M; Thollet A; Beaumont M; Hossu G; Toquet C; Gourraud JB; Trochu JN; Warin-Fresse K; Marie PY; Schott JJ; Roussel JC; Serfaty JM; Selton-Suty C; Le Tourneau T
    Circulation; 2021 May; 143(18):1763-1774. PubMed ID: 33706538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of papillary muscle function using cardiovascular magnetic resonance imaging in mitral valve prolapse.
    Han Y; Peters DC; Kissinger KV; Goddu B; Yeon SB; Manning WJ; Nezafat R
    Am J Cardiol; 2010 Jul; 106(2):243-8. PubMed ID: 20599010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis.
    Gatti M; Santonocito A; Papa FP; D'Ascenzo F; De Filippo O; Gallone G; Palmisano A; Pistelli L; De Ferrari GM; Esposito A; Giustetto C; Fonio P; Faletti R
    Eur Radiol; 2024 Nov; 34(11):7321-7333. PubMed ID: 38844620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse.
    Perazzolo Marra M; Basso C; De Lazzari M; Rizzo S; Cipriani A; Giorgi B; Lacognata C; Rigato I; Migliore F; Pilichou K; Cacciavillani L; Bertaglia E; Frigo AC; Bauce B; Corrado D; Thiene G; Iliceto S
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):e005030. PubMed ID: 27516479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse.
    Guglielmo M; Fusini L; Muscogiuri G; Baessato F; Loffreno A; Cavaliere A; Rizzon G; Baggiano A; Rabbat MG; Muratori M; Tamborini G; Danza LML; Del Torto A; Tonet E; Viani G; Mushtaq S; Conte E; Bonalumi G; Gripari P; Zanobini M; Andreini D; Alamanni F; Pepi M; Guaricci AI; Pontone G
    Eur Radiol; 2021 Feb; 31(2):1100-1109. PubMed ID: 32803414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance.
    Aquaro GD; De Gori C; Grilli G; Licordari R; Barison A; Todiere G; Ianni U; Parollo M; Grigoratos C; Restivo L; De Luca A; Faggioni L; Cioni D; Sinagra G; Di Bella G; Neri E
    Eur Radiol; 2023 Jul; 33(7):4621-4636. PubMed ID: 36692598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance.
    Liu B; Neil DAH; Premchand M; Bhabra M; Patel R; Barker T; Nikolaidis N; Billing JS; Treibel TA; Moon JC; González A; Hodson J; Edwards NC; Steeds RP
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):86. PubMed ID: 33308240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological insights into mitral valve prolapse-induced fibrosis.
    Dieterlen MT; Klaeske K; Spampinato R; Marin-Cuartas M; Wiesner K; Morningstar J; Norris RA; Melnitchouk S; Levine RA; van Kampen A; Borger MA
    Front Cardiovasc Med; 2023; 10():1057986. PubMed ID: 36960475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse.
    Chivulescu M; Aabel EW; Gjertsen E; Hopp E; Scheirlynck E; Cosyns B; Lyseggen E; Edvardsen T; Lie ØH; Dejgaard LA; Haugaa KH
    Europace; 2022 Jul; 24(7):1156-1163. PubMed ID: 35226070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.
    Kitkungvan D; Nabi F; Kim RJ; Bonow RO; Khan MA; Xu J; Little SH; Quinones MA; Lawrie GM; Zoghbi WA; Shah DJ
    J Am Coll Cardiol; 2018 Aug; 72(8):823-834. PubMed ID: 30115220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.